Clinical Trial Update: Evaluation of the Safety and Tolerability of Gemini in Subjects With Stage 3-4 Chronic Kidney Disease. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update reports on the safety and tolerability of the Gemini therapy in subjects with chronic kidney disease (stages 3–4), with the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Gemini

Snippet

Sponsor: Revelation Biosciences, Inc | Conditions: Renal Insufficiency, Chronic, Chronic Kidney Disease stage3 | Phase 1, Phase 2 | Status: COMPLETED